Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David O Williams

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Circulation|September 5, 2025
Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIAChetan P Huded, John A Spertus, Philip G Jones, et al.
Journal of the American College of Cardiology|October 16, 2007
The truth and consequences of the COURAGE trialDean J Kereiakes, Paul S Teirstein, Ian J Sarembock, et al.
JACC. Cardiovascular Interventions|February 13, 2009
Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic RegistrySuresh R Mulukutla, Helen A Vlachos, Oscar C Marroquin, et al.
The New England Journal of Medicine|January 25, 2008
A comparison of bare-metal and drug-eluting stents for off-label indicationsOscar C Marroquin, Faith Selzer, Suresh R Mulukutla, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 27, 2007
The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesionsJeffrey W Moses, Giora Weisz, Gregory Mishkel, et al.
Circulation. Cardiovascular Interventions|February 2, 2010
Paclitaxel-eluting versus sirolimus-eluting stents in diabetes mellitus: a report from the National Heart, Lung, and Blood Institute Dynamic RegistryWilliam M Wolf, Helen A Vlachos, Oscar C Marroquin, et al.
American Heart Journal|May 21, 2018
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design, David J Maron, Judith S Hochman, et al.
American Heart Journal|May 28, 2013
Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery diseaseJeffrey L Carson, Maria Mori Brooks, J Dawn Abbott, et al.
JAMA Cardiology|June 29, 2022
Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney FunctionSripal Bangalore, Judith S Hochman, Susanna R Stevens, et al.
The American Journal of Cardiology|September 6, 2011
Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry)Sandy M Green, Faith Selzer, Suresh R Mulukutla, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Circulation|September 5, 2025
Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIAChetan P Huded, John A Spertus, Philip G Jones, et al.
Journal of the American College of Cardiology|October 16, 2007
The truth and consequences of the COURAGE trialDean J Kereiakes, Paul S Teirstein, Ian J Sarembock, et al.
JACC. Cardiovascular Interventions|February 13, 2009
Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic RegistrySuresh R Mulukutla, Helen A Vlachos, Oscar C Marroquin, et al.
The New England Journal of Medicine|January 25, 2008
A comparison of bare-metal and drug-eluting stents for off-label indicationsOscar C Marroquin, Faith Selzer, Suresh R Mulukutla, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 27, 2007
The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesionsJeffrey W Moses, Giora Weisz, Gregory Mishkel, et al.
Circulation. Cardiovascular Interventions|February 2, 2010
Paclitaxel-eluting versus sirolimus-eluting stents in diabetes mellitus: a report from the National Heart, Lung, and Blood Institute Dynamic RegistryWilliam M Wolf, Helen A Vlachos, Oscar C Marroquin, et al.
American Heart Journal|May 21, 2018
International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design, David J Maron, Judith S Hochman, et al.
American Heart Journal|May 28, 2013
Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery diseaseJeffrey L Carson, Maria Mori Brooks, J Dawn Abbott, et al.
JAMA Cardiology|June 29, 2022
Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney FunctionSripal Bangalore, Judith S Hochman, Susanna R Stevens, et al.
The American Journal of Cardiology|September 6, 2011
Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry)Sandy M Green, Faith Selzer, Suresh R Mulukutla, et al.
Pageof 12